Spiden Announces Breakthrough in Non-Invasive Glucose Monitoring, Adds Key Executive Hires and Secures $15m in Additional Funding

Contributed by: ACCESSWIRE

Logo

Images

Tags

Healthcare & Pharmaceutical

Spiden

Company Update

More Like This

PR Newswire associated0

SIBIONICS to Make Debut at the 59th Annual Meeting of the European Association for the Study of Diabetes (EASD)

PR Newswire associated0

SIBIONICS Achieves Milestone: Receiving CE Mark for Its Groundbreaking GS1 Continuous Glucose Monitoring System

PR Newswire associated0

Zedsen partners with Imperial College Healthcare NHS Trust to clinically validate its novel non-invasive sensing technology

PR Newswire associated0

/C O R R E C T I O N -- Menarini Silicon Biosystems/

PR Newswire associated0

Respiree teams up with Roche Diagnostics in APAC to introduce a new simplified way of hospital patient monitoring

PR Newswire associated0

MTD Group completes the acquisition of Ypsomed's Pen Needles and Blood Glucose Monitoring Systems and announces a significant investment plan for its European production sites

Dexcom ONE+ real-time Continuous Glucose Monitoring (rt-CGM) System (Photo: Business Wire)

Dexcom Launches Dexcom One+ Bringing Powerful, New Diabetes Management Technology to More People

Biognosys Launches Spectronaut 19 and Presents Advances with Its Research Platforms at the ASMS 2024 Annual Conference